Hepion shareholders approve reverse stock split; Board to set ratio 1:2 to 1:20
Hepion Pharmaceuticals, Inc.
- Special meeting held Dec 15, 2022; proposal to amend charter for reverse split approved.
- Vote: 6,757,528,739 for, 3,262,017,173 against, 38,856,945 abstained; 0 broker non-votes.
- Board authorized to select ratio between 1:2 and 1:20 within one year of meeting.
- Proposal covers all outstanding common and preferred shares as of Nov 8, 2022 record date.